Selected References:
- Anderka M, et al. 2012. National Birth Defects Prevention Study. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol; 94:22-30.
- Andersen ABT, et al. 2012. Prenatal exposure to acid-suppressive drugs and the risk of toddler asthma: a population-based Danish cohort study. Alim Pharmacol Ther; 35:1190-1198.
- Dehlink E, et al. 2009. First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study. Clin Exp Allergy 39:246-53.
- Diav-Citrin O, et al. 2005. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther; 21:269-75.
- Erichsen R, et al. 2014. Maternal use of proton pump inhibitors during early pregnancy and the prevalence of hypospadias in male offspring. Am J Ther; 21: 254-259.
- Gill SK et al. 2009. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol; 104(6): 1541-1545.
- Huijgen, N. A.,(2016). Are proton-pump inhibitors harmful for the semen quality of men in couples who are planning pregnancy?. Fertility and Sterility, 106(7), 1666-1672.
- Kallen B. 1998. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol; 105:877-881.
- Keihani, S. et al. (2018). Proton-pump inhibitor use does not affect semen quality in subfertile men. Asian journal of andrology, 20(3), 290.
- Lalkin A, et al. 1998. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol; 179(3 Pt 1): 727-730.
- Mahadevan, Uma. 2007. “Gastrointestinal Medications in Pregnancy.” Best Practice & Research Clinical Gastroenterology 21(5): 849–77.
- Majithia, R., & Johnson, D. A. (2012). Are Proton Pump Inhibitors Safe during Pregnancy and Lactation? 10.
- Marshall JK, et al. 1998. Omeprazole for refractory gastroesophageal reflux disease during pregnancy and lactation. Can J Gastroenterol; 12: 225-227.
- Matok I, et al. 2012. The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci; 57:699-705.
- Medical management of gastroesophageal reflux disease in adults – UpToDate. (n.d.). Retrieved August 18, 2020, from https://www.uptodate.com/contents/medical-management-of-gastroesophageal-reflux-disease-in-adults?
- Nava-Ocampo et al. (2006). Use of proton pump inhibitors during pregnancy and Canadian Family Physician, 52(7), 853–854.
- Nikfar S, et al. 2002. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci; 47:1526-9.
- Pasternak B, Hviid A. 2010. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med; 363:2114-2123.
- Saito, J. et al. (2020). Esomeprazole During Pregnancy and Lactation: Esomeprazole Levels in Maternal Serum, Cord Blood, Breast Milk, and the Infant’s Serum. Breastfeeding Medicine, bfm.2020.0175.
- Servey, Jessica T., and Jennifer G. Chang. 2014. “Over-the-Counter Medications in Pregnancy.” American Family Physician 90(8): 548–55.
- Thélin, C. S., & Richter, J. E. (2020). Review article: the management of heartburn during pregnancy and lactation. Alimentary Pharmacology & Therapeutics, 51(4), 421–434.
- Yitshak-Sade M, et al. 2016. Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring. J Clinic Pharmacol; 56: 116-123
